Skip to main content
Photochemical

Photodynamic Therapy (PDT)

Adjunct to SRP for bacterial reduction in periodontal pockets.

🟠Emerging Evidence

Early studies and pilot data show promise, but larger trials are needed.

Overview

What is it?

Antimicrobial photodynamic therapy (aPDT) combines a photosensitizing agent (commonly methylene blue or toluidine blue) with a specific wavelength of light to produce reactive oxygen species that kill bacteria.

How does it work?

A photosensitizer is applied to periodontal pockets where it binds to bacterial cells. When illuminated with light of the matching wavelength (typically 660–670 nm for methylene blue), the photosensitizer enters an excited state and transfers energy to molecular oxygen, generating singlet oxygen and free radicals that damage bacterial cell membranes and organelles.

When is it commonly used?

Used as an adjunct to SRP for chronic and aggressive periodontitis, peri-implantitis, and in endodontic disinfection. Applied immediately after mechanical debridement.

Mechanism of Action

The photosensitizer preferentially binds to bacterial cell membranes via electrostatic interactions (bacterial membranes are negatively charged). Upon light activation, the photosensitizer transitions to a triplet excited state and generates singlet oxygen (Type II photochemical reaction) or superoxide/hydroxyl radicals (Type I reaction). These reactive oxygen species cause oxidative damage to bacterial membranes, proteins, and DNA. The effect is localized and non-specific, reducing resistance risk.

Organisms Studied

OrganismAbbr.Research Finding
Porphyromonas gingivalisPgSignificantly reduced by methylene blue-mediated PDT as adjunct to SRP in clinical trials.
Fusobacterium nucleatumFnSensitive to PDT in both planktonic and biofilm forms.
Aggregatibacter actinomycetemcomitansAaReduced by PDT; some studies show effectiveness comparable to local antibiotics.
Tannerella forsythiaTfReduced in clinical studies of PDT adjunct to SRP.
Candida albicansCaPDT effective against Ca in oral candidiasis models.

Evidence Summary

Benefits

  • Broad-spectrum antimicrobial without resistance risk
  • No systemic side effects
  • Can be repeated safely
  • Effective against biofilm-embedded bacteria

Limitations

  • Effect is localized and short-term
  • Requires specialized equipment (light source + photosensitizer)
  • Added time and cost per visit
  • Optimal protocols (dose, exposure time, photosensitizer concentration) not standardized

Quality of Evidence

Systematic reviews show modest adjunctive benefit over SRP alone, but studies vary in protocol and quality. Evidence is emerging.

Key Clinical Takeaways

  • 1A safe adjunct with no resistance risk
  • 2Benefits are modest and protocols need standardization
  • 3May be particularly useful for patients with antibiotic allergies or resistance concerns

Evidence Meter

🟠Emerging Evidence

Early studies and pilot data show promise, but larger trials are needed.

Frequently Asked Questions

References

Antimicrobial photodynamic therapy in periodontitis: A systematic review and meta-analysis

Sgolastra F et al. (2013)

DOI: 10.1111/jcpe.12864

Photodynamic therapy in periodontics: A systematic review

Azarpazhooh A et al. (2014)

DOI: 10.4103/0975-7406.163453

Organisms Studied with This Therapy

Related Therapies

Educational use only. This page provides general information and does not recommend this therapy over others or provide medical advice. Always consult a licensed dental or medical professional for diagnosis and treatment decisions.